Medipal Holdings stock forecast
Want to see JP:7459 full AI Analyst Report?
Medipal Holdings (7459) Stock Forecast & Price Target
7459 Analyst Ratings
7459 Stock 12 Month Forecast
Detailed List of Analyst Forecasts
| Price Target | Article | |||||||
|---|---|---|---|---|---|---|---|---|
| Miyabi Yamakita | Jefferies | ¥2,900 | hold | -7.70%Downside | Reiterated | 07/28/26 |
| Rating | Article | ||||
|---|---|---|---|---|---|
| Miyabi YamakitaJefferies | HoldReiterated¥2,900 | 07/28/26 | -7.70%Downside |
Best Analysts Covering Medipal Holdings
Copying PerPlexity Medical - Distribution's trades and holding each position for 3 Months would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
Copying PerPlexity Medical - Distribution's trades and holding each position for 1 Year would result in 50.00% of your transactions generating a profit, with an average return of +4.45% per trade.
Copying PerPlexity Medical - Distribution's trades and holding each position for 2 Years would result in 50.00% of your transactions generating a profit, with an average return of +4.45% per trade.
7459 Analyst Recommendation Trends
| Rating | Jul 26 | Aug 26 | Sep 26 | Oct 26 | Nov 26 |
|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| total | 1 | 1 | 1 | 0 | 0 |
In the current month, 7459 has received 0 Buy Ratings, 0 Hold Ratings, and 0 Sell Ratings. 7459 average Analyst price target in the past 3 months is ―.
7459 Financial Forecast
7459 Earnings Forecast
Next quarter’s earnings estimate for 7459 is JPY 75.43 with a range of JPY 74.68 to JPY 76.17. The previous quarter’s EPS was JPY 45.82. Its overall industry beat the EPS estimate 57.80% of the time in the past 12 months.
7459 Sales Forecast
Next quarter’s sales forecast for 7459 is JPY 1.04T with a range of JPY 1.03T to JPY 1.04T. The previous quarter’s sales results were JPY 980.12B. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.
